Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Conforti

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Rheumatology|February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experienceS Bellando-Randone, C Bruni, G Lepri, et al.
Rheumatology (Oxford, England)|February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosisF Bartoli, C Angotti, C Fatini, et al.
Respiration; International Review of Thoracic Diseases|October 22, 2008
Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavageN Damjanov, P Ostojic, O Kaloudi, et al.
Rheumatology (Oxford, England)|August 29, 2006
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosisO Kaloudi, G Basta, F Perfetto, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Rheumatology|February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experienceS Bellando-Randone, C Bruni, G Lepri, et al.
Rheumatology (Oxford, England)|February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosisF Bartoli, C Angotti, C Fatini, et al.
Respiration; International Review of Thoracic Diseases|October 22, 2008
Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavageN Damjanov, P Ostojic, O Kaloudi, et al.
Rheumatology (Oxford, England)|August 29, 2006
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosisO Kaloudi, G Basta, F Perfetto, et al.
Pageof 2